FAIRPORT, N.Y., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seneca Foods Corporation (NASDAQ: SENEA, SENEB) today announced financial results for the second quarter and six months ended September 28 ...

SAN JOSE, Calif., Jan. 21, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer ...

The Biotech Beach Hotbed includes San Diego, Los Angeles and the surrounding (Torrey Pines, Thousand Oaks) regions of Southern California. SoCal is well-known for its sprawling beaches and ...

OpenAI teamed up with Retro Biosciences to build a machine learning model focused on generating new proteins. The new model, called GPT-4b, is a custom version of OpenAI’s GPT-4o model built ...

The protein engineering project started a year ago when Retro Biosciences, a longevity research company based in San Francisco, approached OpenAI about working together. That link-up did not ...

In a move that blurs the line between science fiction and reality, Colossal Biosciences, the pioneering de-extinction company backed by countless celebs, has secured $200 million in Series C funding.

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

Biotechnology start-up Colossal Biosciences Inc., which is using DNA and genomics in an attempt to re-introduce extinct animals, hopes to bring that tusked beast back in the world by late 2028.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Dallas-based Colossal Biosciences is making history—again. The world’s first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, has become ...